Taking a New Approach to Stem Cell Regulation
Policing clinics isn’t the right move; instead, the FDA needs to consider the concerns of key stakeholders.
Editorial by:
Ana Iltis, PhD, Wake Forest University & Kirstin Matthews, PhD, Rice University
Publication:
See the Houston Chronicle, December 15, 2015: View Editorial